Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Combined methylmalonic acidemia and homocystinuria
(cblC)
is the most common inborn error of intracellular cobalamin metabolism and due to mutations in
Methylmalonic Aciduria type C and Homocystinuria (MMACHC)
. Recently, mutations in the transcriptional regulators
HCFC1
and
RONIN (THAP11)
were shown to result in cellular phenocopies of
cblC
. Since HCFC1/RONIN jointly regulate
MMACHC
, patients with mutations in these factors suffer from reduced
MMACHC
expression and exhibit a
cblC
-like disease. However, additional de-regulated genes and the resulting pathophysiology is unknown. Therefore, we have generated mouse models of this disease. In addition to exhibiting loss of
Mmachc
, metabolic perturbations, and developmental defects previously observed in
cbl
C, we uncovered reduced expression of target genes that encode ribosome protein subunits. We also identified specific phenotypes that we ascribe to deregulation of ribosome biogenesis impacting normal translation during development. These findings identify HCFC1/RONIN as transcriptional regulators of ribosome biogenesis during development and their mutation results in complex syndromes exhibiting aspects of both
cblC
and ribosomopathies.
Combined methylmalonic acidemia (MMA) and hyperhomocysteinemias are inborn errors of vitamin B12 metabolism, and mutations in the transcriptional regulators HCFC1 and RONIN (THAP11) underlie some forms of these disorders. Here the authors generated mouse models of a human syndrome due to mutations in RONIN (THAP11) and HCFC1, and show that this syndrome is both an inborn error of vitamin B12 metabolism and displays some features of ribosomopathy.